Astera Labs (ALAB) CEO receives 26,522 RSUs and reports major trust holdings
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Astera Labs, Inc. reported an equity grant to its Chief Executive Officer and director, Mohan Jitendra. On February 6, 2026, he received 26,522 shares of common stock as restricted stock units at $0 per share under the 2024 Stock Option and Incentive Plan.
The RSUs vest as to 25% on February 15, 2027, with the remaining units vesting in 12 equal quarterly installments, contingent on continued service. Following this grant, he directly holds 1,547,710 shares of common stock. Additional common shares are held indirectly through a living trust and several estate-planning trusts that are associated with him, for which he disclaims beneficial ownership except for any pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
7 transactions reported
Mixed
7 txns
Insider
Mohan Jitendra
Role
Chief Executive Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 26,522 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 1,547,710 shares (Direct);
Common Stock — 4,689,232 shares (Indirect, By Living Trust)
Footnotes (1)
- These shares represent an award of restricted stock units ("RSUs") granted on February 6, 2026 under the Astera Labs, Inc. 2024 Stock Option and Incentive Plan. Such award provides that the RSUs shall vest as to 25% on February 15, 2027 and the remaining RSUs shall vest in 12 equal quarterly installments thereafter, subject to the Reporting Person's continuous service relationship with the Issuer through each applicable vesting date. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. These shares are owned directly by a living trust (the "Living Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. These shares are owned directly by an estate planning trust (the "Trust"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. These shares are owned directly by an estate planning trust (the "2021 Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. These shares are owned directly by an estate planning trust (the "2021 Trust 2"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. These shares are owned directly by an estate planning trust (the "2022 Trust 1"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. These shares are owned directly by an estate planning trust (the "2022 Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
FAQ
What insider transaction did Astera Labs (ALAB) disclose for Mohan Jitendra?
Astera Labs disclosed that CEO and director Mohan Jitendra received 26,522 restricted stock units on February 6, 2026. These RSUs convert into common shares over time, providing equity-based compensation linked to his ongoing service with the company.
How do the 26,522 RSUs for Astera Labs (ALAB) CEO vest over time?
The 26,522 RSUs granted to Astera Labs’ CEO vest 25% on February 15, 2027. The remaining units vest in 12 equal quarterly installments thereafter, conditioned on his continuous service relationship with the company at each vesting date.
What is Mohan Jitendra’s direct common stock holding in Astera Labs (ALAB) after this grant?
After the February 6, 2026 grant, Mohan Jitendra directly holds 1,547,710 shares of Astera Labs common stock. This direct position is in addition to various indirect holdings through trusts that are associated with his estate and financial planning.
What stock plan governed the 26,522 RSU grant at Astera Labs (ALAB)?
The 26,522 RSUs granted to the Astera Labs CEO were issued under the Astera Labs, Inc. 2024 Stock Option and Incentive Plan. Each RSU represents a contingent right to receive one share of the company’s common stock upon vesting.